Novel CAR T cells drive high objective response rate in multiple myelomaJune 12, 2017Hematologic MalignanciesMultiple Myeloma
Smoldering myeloma progressed more rapidly in patients with elevated BMIsMay 19, 2017Multiple Myeloma
Myeloma patients who get solid tumor cancers do as well as other cancer patientsMay 19, 2017Multiple Myeloma
In sickle cell disease, osteomyelitis is a tough callMay 3, 2017Infectious DiseasesHematologic Malignancies
Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Multiple MyelomaInfectious DiseasesVaccinesOncologyHematologic Malignancies
Pembrolizumab ‘new standard of care’ in advanced PD-L1-rich NSCLCOctober 17, 2016Lung CancerImmuno-oncology
Pembrolizumab boosts response but not survival in small study of advanced NSCLCOctober 13, 2016Lung CancerImmuno-oncology
Glimmer of promise for nivolumab in neoadjuvant NSCLC therapyOctober 7, 2016Lung CancerImmuno-oncology
